Company / R&D per Share
CareDx, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.30
FY2025
5-year range
$1.30 / $1.71
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#62 of 103
Health Care
What the data says
At $1.30, CareDx, Inc.'s r&d per share ranks #62 of 103 in the Health Care sector. R&D per Share has declined for 3 consecutive years, from $1.71 in FY2022 to $1.30 in FY2025.
Based on SEC 10-K filings.
1.30 in FY2025 with a 5-year CAGR of +2.5%.
Declined from $1.54 to $1.30 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -8.6%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
#62 of 103 in Health CareTop 60% of 103This company $1.30 Sector average $2.13
▼
-38.8% below sector average
Key checks
Key Insights
- CareDx, Inc.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 1.5% year-over-year.
- Ranks #62 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.30 | -1.5% |
| FY2024 | $1.32 | -14.0% |
| FY2023 | $1.54 | -9.9% |
| FY2022 | $1.71 | +10.3% |
| FY2021 | $1.55 | +34.4% |
| FY2020 | $1.15 | +55.2% |
| FY2019 | $0.74 | +47.4% |
| FY2018 | $0.50 | -13.5% |
| FY2017 | $0.58 | -44.1% |
| FY2016 | $1.04 | +31.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026